Atopic Dermatitis: Update on Pathogenesis and Therapy
Authors:
- 1 March 2020
- journal article
- research article
- Published by SLACK, Inc. in Pediatric Annals
- Vol. 49 (3) , E140-E146
Abstract
Atopic dermatitis (AD) is the most common inflammatory skin condition in pediatric patients. AD has long been associated with comorbidities including food allergies, asthma, and allergic rhinitis, but recent literature has expanded this list to include attention-deficit/hyperactivity disorder and depression. AD has tremendous impact on quality of life for both affected children and their families. Improved understanding of AD pathogenesis, particularly regarding skin barrier dysfunction, the role of the cutaneous microbiome, and immune dysregulation, has spawned exciting new therapeutic directions. Although good skin care and appropriate use of topical corticosteroids remain first-line treatment, more precisely targeted treatments hold great promise. A recently approved topical phosphodiesterase inhibitor, crisaborole, and a subcutaneously administered interleukin-4/interleukin-13 blocker, dupilumab, are the first of what will likely be many new treatment options for patients with AD.Keywords
This publication has 27 references indexed in Scilit:
- Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adultsBritish Journal of Dermatology, 2016
- Association Between Malignancy and Topical Use of PimecrolimusJAMA Dermatology, 2015
- Atopic Dermatitis: Skin-Directed ManagementPediatrics, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's HealthJournal of Investigative Dermatology, 2011
- Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease SeverityPediatrics, 2009
- Atopic DermatitisNew England Journal of Medicine, 2008
- The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic ReviewPediatric Dermatology, 2008
- Endogenous Antimicrobial Peptides and Skin Infections in Atopic DermatitisNew England Journal of Medicine, 2002